title: Hydroxyurea is associated with reductions in hypercoagulability markers in sickle cell anemia.
authors: M P
authors: MP
authors: Colella
authors: E V
authors: EV
authors: De Paula
authors: N
authors: N
authors: Conran
authors: J A
authors: JA
authors: Machado-Neto
authors: J M
authors: JM
authors: Annicchino-Bizzacchi
authors: F F
authors: FF
authors: Costa
authors: S T O
authors: ST
authors: Saad
authors: F
authors: F
authors: Traina
mesh_terms: D000755:Anemia, Sickle Cell / Q000097:blood / Q000188:drug therapy*; D015415:Biomarkers / Q000097:blood*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D060888:Real-Time Polymerase Chain Reaction
chemical_list: D015415:Biomarkers; D006918:Hydroxyurea